Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 11/20 | 0.35 |
| ▸ | MAOB | P27338 | 8/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27480853 | 0.98 | NPC1 (0.42) | NPC1RAB9AMAPTLMNAMAPK1 | |
| SCHEMBL15266429 | 0.82 | SHBG (0.36) | NPC1RAB9AMAPTSMN1; SMN2TAAR1 | |
| SCHEMBL2447289 | 0.81 | CNR2 (0.39) | CNR2TAAR1 | |
| SCHEMBL779443 | 0.81 | NPC1 (0.58) | NPC1RAB9AMAPTLMNAMAPK1 | |
| SCHEMBL1943661 | 0.80 | ALDH1A1 (0.31) | — | |
| SCHEMBL6891134 | 0.80 | ESR1 (0.41) | MAPT | |
| SCHEMBL317457 | 0.78 | CNR1 (0.38) | SMN1; SMN2CNR2TAAR1 | |
| SCHEMBL16035570 | 0.78 | TAAR1 (0.33) | TAAR1 | |
| SCHEMBL21684968 | 0.78 | TAAR1 (0.33) | TAAR1 | |
| SCHEMBL3596579 | 0.78 | TAAR1 (0.60) | NPC1RAB9AMAPTTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 909 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217923-A1 | A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION | BASF (CHINA) COMPANY LIMITED (CN) | 2024-07-04 | — | — | US | claimed |
| EP-3726636-B1 | ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTROLYTE BATTERIES AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | CENTRAL GLASS CO LTD (JP) | 2024-06-26 | — | — | EP | claimed |
| US-11987588-B2 | Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2024-05-21 | — | — | US | claimed |
| CN-115368630-B | Liquid antioxidant composition for raw rubber and application thereof | 天津利安隆新材料股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| EP-4330226-A1 | A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION | BASF SE (DE) | 2024-03-06 | — | — | EP | claimed |
| CN-117203185-A | Diisocyanate stabilizer, use thereof and diisocyanate composition | 巴斯夫欧洲公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116332978-B | Organic compound, preparation method thereof and organic electroluminescent device comprising organic compound | 吉林奥来德光电材料股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-111527636-B | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2023-08-15 | — | — | CN | claimed |
| CN-111433962-B | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2023-07-14 | — | — | CN | claimed |
| CN-116332978-A | Organic compound, preparation method thereof and organic electroluminescent device comprising organic compound | 吉林奥来德光电材料股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| WO-2000078733-A1 | PHENOXY FLUOROPYRIMIDINES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-12-28 | — | — | WO | claimed |
| WO-2000016624-A1 | SAFE AND EFFECTIVE BIOFILM INHIBITORY COMPOUNDS AND HEALTH-RELATED USES THEREOF | PHYCOGEN, INC. (US) | 2000-03-30 | — | — | WO | claimed |
| US-6022873-A | Metalloproteinase inhibitors | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2000-02-08 | — | — | US | claimed |
| EP-0934292-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1999-08-11 | — | — | EP | claimed |
| WO-1998017655-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1998-04-30 | — | — | WO | claimed |
| US-5296579-A | From (hydro)sulfide, polyhalogenated aromatic compound and a mercaptan | PHILLIPS PETROLEUM COMPANY (US) | 1994-03-22 | — | — | US | claimed |
| EP-0568344-A1 | Fluoran compounds and process for their production | FUJI PHOTO FILM CO., LTD. (JP) | 1993-11-03 | — | — | EP | claimed |
| US-5231105-A | Ethylamine derivatives and antihypertensives containing the same | AJINOMOTO CO., INC. (JP) | 1993-07-27 | — | — | US | claimed |
| US-4134877-A | Flame retardant phosphoramidate compositions | MONSANTO COMPANY (US) | 1979-01-16 | — | — | US | claimed |
| US-4089972-A | Organotin sulfinates as insecticides and acaricides | UNIROYAL, INC. (US) | 1978-05-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11987588-B2 | Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto | ADRB3, ADRB1, ADRB2 | NPC1 1553/4885RAB9A 2400/4885MAPT 3454/4885 |
| US-20240217923-A1 | A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION | TST, DDT, PAH | NPC1 3821/4885RAB9A 3766/4885MAPT 797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.